📣 REMINDER: CALL FOR ABSTRACTS & CLINICAL CASES FOR #ESHCMLMPN2025 Submit yours here ➡ https://bit.ly/4cjz0oy 4th How to Diagnose and Treat CML/MPN 🗓️ Join us on March 7-9, 2025 in Vienna, Austria 🇦🇹 Chairs: Claire Harrison, Andreas Hochhaus, Ruben Mesa, MD #ESHCONFERENCES #HAEMATOLOGY #HEMATOLOGY #MPNsm #CMLsm British Society for Haematology DGHO Service GmbH
European School of Haematology (ESH)’s Post
More Relevant Posts
-
Happening today! Clinical management of patients with clonal hematopoiesis is an area of active investigation. Learn about the range of clinical implications associated with these conditions and emerging approaches to management. https://ow.ly/wy5y50T8VBy #hematology #molpath
To view or add a comment, sign in
-
Hematology analyzers are revolutionizing modern clinical labs, delivering crucial insights into blood composition for diagnosing and monitoring various disorders. With technological advancements, these tools now offer enhanced performance, accuracy, and efficiency. Discover the latest advancements in hematology analyzers in our blog post and learn how Erba Transasia is leading the way in hematology analysis. Read on https://zurl.co/gBlS #IAmTransasia #WeAreErba #Hematology #IVD #clinicalanalysis #labmedicine #blog #innovation #advancedhematology
To view or add a comment, sign in
-
Medical Laboratory Technologist | Molecular Biology & Cancer Research Enthusiast | Expert in Serology, ELISA, Clinical Chemistry, Biosafety & Biosecurity | Quality Control | ASM, ESMO & MLTAP Member
🩸 #QUIZ Basic Hematology Concepts and Laboratory Procedures 🩸 1. Insufficient centrifugation will result in: A. A false increase in hematocrit (Hct) value B. A false decrease in Hct value C. No effect on Hct value D. All of these options, depending on the patient 2. Variation in red cell size observed on the peripheral smear is described as: A. Anisocytosis B. Hypochromia C. Poikilocytosis D. Pleocytosis 3. Which of the following is the preferable site for bone marrow aspiration and biopsy in an adult? A. Iliac crest B. Sternum C. Tibia D. Spinous processes of a vertebra 4. Mean cell volume (MCV) is calculated using the following formula: A. (Hgb ÷ RBC) × 10 B. (Hct ÷ RBC) × 10 C. (Hct ÷ Hgb) × 100 D. (Hgb ÷ RBC) × 100 5. What term describes the change in shape of erythrocytes seen on a Wright’s-stained peripheral blood smear? A. Poikilocytosis B. Anisocytosis C. Hypochromia D. Polychromasia . . . . . . . #Hematology #LaboratoryMedicine #MedicalLaboratory #Healthcare #BloodBanking #Pathology #ClinicalLaboratory #Biomedicine #LabTech #MedicalEducation #HealthcareProfessionals #ContinuingEducation #RBCIndices
To view or add a comment, sign in
-
Hematology analyzers are revolutionizing modern clinical labs, delivering crucial insights into blood composition for diagnosing and monitoring various disorders. With technological advancements, these tools now offer enhanced performance, accuracy, and efficiency. Discover the latest advancements in hematology analyzers in our blog post and learn how Erba Transasia is leading the way in hematology analysis. Read on https://zurl.co/gBlS #IAmTransasia #WeAreErba #Hematology #IVD #clinicalanalysis #labmedicine #blog #innovation #advancedhematology
To view or add a comment, sign in
-
#Cannabis #arteritis (CA) is a rare vasculopathy (<100 reported cases) clinically identical to #tobacco-associated #thromboangiitis obliterans (TAO) in its involvement of the small- and medium-sized blood vessels of the peripheral vasculature. The concurrent use of tobacco and cannabis in makes the unconfounded characterization of CA challenging, however, its histopathology demonstrates non-inflammatory changes, contrasting the inflammatory process of TAO. This supports the hypothesis that CA may be more of a secondary #thrombotic process in the setting of arterial #vasospasm as opposed to a primarily inflammatory pathology. *Kaniecki T, Huso TH, Haque UJ. Cannabis arteritis revisited: a case report with distinct pathologic features and review of the literature. Rheumatology (Oxford). 2024;63(6):e190-e192. 🔗https://lnkd.in/dyv7t3U3
To view or add a comment, sign in
-
#AAO2024: Dazdotuftide (TRS01, Tarsier Pharma) treats noninfectious anterior uveitis with superior intraocular pressure (IOP) outcomes compared with steroid treatment, according to the results of a phase 3, double-blind study presented at the American Academy of Ophthalmology’s 2024 Annual Meeting held in Chicago, from October 18 to 21, 2024. Researchers included David Chu, MD, a professor at the Rutgers New Jersey Medical School, and Ron Neumann, MD. Read here: https://bit.ly/3AmsCyB #Dazdotuftide #TRS01 #NoninfectiousAnteriorUveitis #Uveitis #IntraocularPressure #IOP #SteroidTreatment #Phase3Study #ClinicalTrials #Ophthalmology #EyeCare
To view or add a comment, sign in
-
📕 Unlock the Complexities of Platelets: A Comprehensive Resource for Professionals Excited to explore a comprehensive guide that delves into every aspect of platelet biology, from their discovery and functions to advanced counting methods and clinical applications. This in-depth resource covers crucial topics like thrombopoiesis, accurate platelet counting, managing thrombocytopenia, and emerging insights on reticulated platelets. Whether you're a healthcare professional, researcher, or involved in transfusion medicine, this guide offers valuable, evidence-based knowledge that can enhance your understanding and practice in the field of hematology. Highly recommend for those looking to stay ahead in platelet research and patient care. #Hematology #PlateletBiology #Thrombopoiesis #TransfusionMedicine #ClinicalResearch #HealthcareProfessionals #MedicalScience
To view or add a comment, sign in
-
Pharmacogenomics-derived precision medicine approaches hold significant clinical relevance by improving efficacy and reducing toxicity to achieve optimal and desirable response in patients. In this webinar, learn about use of pharmacogenetics data for precision medicine approaches in malignant hematologic disorders. This webinar is the latest in a live series on precision hematology sponsored by the ASH Subcommittee on Precision Medicine. Through this series, hematology clinicians and researchers will learn foundational information on the latest technologies available for data acquisition, discovery, diagnosis, and decision-making for hematologic diseases. Enroll here: https://ow.ly/noJR50TzwRz #MalignantHematology #PrecisionMedicine #PrecisionHematology #Hematology #MalignantHematology #ASHTrainee #Pharmacogenetics
To view or add a comment, sign in
-
Acromegaly is a rare debilitating endocrine disease characterised by hypersecretion of growth hormone (GH). It is generally accepted that the clinical manifestations of acromegaly are mediated through elevations in serum IGF-I concentrations. Somavert is indicated for the treatment of patients with acromegaly who have had an inadequate response to surgery and/or radiation therapy and in whom an appropriate medical treatment with somatostatin analogues did not normalize IGF-I concentrations or was not tolerated. Pegvisomant, the active substance in Somavert, is a 40-50 kDa molecular variant of the human growth hormone (hGH) consisting of recombinant protein component and polyethylene glycol (PEG). The protein molecule (B2036) is modified by covalent addition of polyethylene glycol (PEG) molecules resulting in a pegylated protein (B2036-PEG) with 4 and 5 PEG groups per B2036-PEG molecule. https://lnkd.in/eANMFJvW #Pegvisomant #peg
To view or add a comment, sign in
-
✅ This week, Novartis received FDA accelerated approval for #Fabhalta (iptacopan), making it the first complement inhibitor approved for IgAN. Though it will be third to enter the market, Spherix’s latest IgAN market tracking study highlights Fabhalta's potential to shake up the current landscape. The study shows that half of the surveyed nephrologists anticipate prescribng Fabhalta to at least one IgAN patient within the first six months, potentially positioning it ahead of #Tarpeyo and #Filspari at similar stages of their launches. 📈 Starting next month, we’ll begin our monthly tracking of Fabhalta’s launch in IgAN! #nephrology #IgAN #marketresearch
To view or add a comment, sign in
2,562 followers